chr14-50118599-C-A
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006939.4(SOS2):c.3744G>T(p.Trp1248Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000517 in 1,613,912 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006939.4 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 9Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SOS2 | NM_006939.4 | c.3744G>T | p.Trp1248Cys | missense_variant | Exon 23 of 23 | ENST00000216373.10 | NP_008870.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152028Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000489 AC: 123AN: 251468 AF XY: 0.000471 show subpopulations
GnomAD4 exome AF: 0.000529 AC: 774AN: 1461884Hom.: 1 Cov.: 33 AF XY: 0.000505 AC XY: 367AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000401 AC: 61AN: 152028Hom.: 0 Cov.: 31 AF XY: 0.000269 AC XY: 20AN XY: 74274 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:3
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Variant summary: SOS2 c.3744G>T (p.Trp1248Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00049 in 251468 control chromosomes. The observed variant frequency is approximately 195 fold of the estimated maximal expected allele frequency for a pathogenic variant in SOS2 causing Noonan Syndrome and Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is benign. c.3744G>T has been reported in the literature in sequencing studies of individuals affected with Rasopathies (Cordeddu_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Noonan Syndrome and Related Conditions. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign (n=1)/likely benign(n=1). Based on the evidence outlined above, the variant was classified as benign.
Noonan syndrome 9 Benign:2
not provided Benign:1
SOS2: BP4
SOS2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Noonan syndrome and Noonan-related syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at